Tag: NYSE:EC

  • Trader’s Alert: Petroleo Brasileiro Petrobras (NYSE:PBR), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Ecopetrol S.A. (NYSE:EC), VIVUS, Inc. (NASDAQ:VVUS), GAS NATURAL ADR (OTCMKTS:GASNY)

    Brazilian state-run energy giant, Petroleo Brasileiro SA or Petrobras SA (ADR) (NYSE:PBR) on 21 may reported the completion of formation test on well 1-SPS-98. The well is located offshore São Paulo, at water depth of roughly 1,871 meters. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) net profit margin is 8.50% and weekly performance is -2.42%. On last trading day company shares ended up $14.91. Analysts mean target price for the company is $18.74. Petroleo Brasileiro Petrobras SA (ADR) (NYSE:PBR) distance from 50-day simple moving average (SMA50) is 10.52%.

    Ariad Pharmaceuticals Inc. (NASDAQ:ARIA) shareholders urged a Massachusetts federal judge to not toss a consolidated class action over alleged false statements about Ariad’s failed leukemia drug Iclusig, saying on 22 may that prior to a $310 million insider stock sale, the oncology company’s directors concealed evidence that the drug would fail. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) shares fell -0.63% in last trading session and ended the day on $6.30. ARIA gross Margin is 79.20% and its return on assets is -66.50%.Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) quarterly performance is -27.00%.

    Ecopetrol SA (ADR) (NYSE:EC) Colombia’s state-owned oil producer, on 21 may sold $2 billion of 31-year bonds as borrowing costs for longer-dated debt fall to the lowest in almost a year. Ecopetrol S.A. (ADR) (NYSE:EC) shares moved down -0.51% in last trading session and was closed at $37.10, while trading in range of $36.72 – $37.57. Ecopetrol S.A. (ADR) (NYSE:EC) year to date (YTD) performance is 3.31%.

    VIVUS, Inc. (NASDAQ:VVUS) on May 15 announced that a poster describing results of an analysis of the association between weight loss with Qsymia® (phentermine and topiramate extended-release) capsules CIV and annual concomitant medication costs will be presented at the AACE 23rd Annual Scientific & Clinical Congress at the Paris Las Vegas Hotel, Las Vegas, NV. VIVUS, Inc. (NASDAQ:VVUS) ended the last trading day at $4.64. Company weekly volatility is calculated as 3.05% and price to cash ratio as 1.52.VIVUS, Inc. (NASDAQ:VVUS) showed a negative weekly performance of -3.93%.

    GAS NATURAL ADR (OTCMKTS:GASNY) shares moved up 0.36% in last trading session and was closed at $5.65, while trading in range of $5.65 – $5.65.